About MarvelBiome
MarvelBiome is a Healthcare company based in Woburn (United States) founded in 2019 by Priti Chatter, Amaranath Govindan, Rudolph Tanzi, Elam Jayamani, and Gary Ruvkun. Novel therapeutics are developed using microbiome isolation and characterization. MarvelBiome has raised $52.66 million across 3 funding rounds. The company has 10 employees. MarvelBiome offers products and services including Microbiome Research Service and Wellness Innovation Platform. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is MARVELBIOME INC. Its competitors include BridgeBio, Spark Therapeutics and Alnylam; 3 of its 3 listed competitors have raised funding.
Company details
MarvelBiome was founded in 2019 and is headquartered in Woburn, United States. Focus is placed on biotechnology operations involving the microbiome for therapeutic development. Microbial populations are isolated, identified, and characterized through assay methods and bacterial genetic techniques. Services support the creation of treatments based on microbial insights, serving the health sector with research-driven approaches.
- Headquarters Woburn, United States
- Employees 10
- Founders Priti Chatter, Amaranath Govindan, Rudolph Tanzi, Elam Jayamani, Gary Ruvkun
- SectorsHealthcare
- Email••••••••
- Website marvelbiome.com
- Legal Name Marvelbiome Inc
- Total Equity Funding$52.66M (USD)
in 3 rounds
- Latest Funding Round$39.56M (USD), Series C
Oct 2025
- Employee Count10
Products & Services of MarvelBiome
MarvelBiome offers a comprehensive portfolio of products and services, including Microbiome Research Service and Wellness Innovation Platform.
Service identifying therapeutic value of microbiome for health applications.
Platform supporting microbiome studies for therapeutic advancements.
Funding Insights of MarvelBiome
MarvelBiome has successfully raised a total of $52.66M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $39.56 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $52.66M
- Total Rounds 3
- Last Round Series C — $39.56M
- First Round $3.1M
(Nov 2020)
All 3 funding rounds of MarvelBiome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $39.56M | Series C | – | – | – |
| Aug 2023 | $10M | Series B | – | – | – |
| Nov 2020 | $3.1M | Series A | – | – | – |
People of MarvelBiome
14 people are tracked at MarvelBiome (5 in leadership, 9 in board & advisors); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Priti Chatter | Co-Founder | Leadership |
Amaranath Govindan | Co-Founder & Chief Scientific Officer | Leadership |
Rudolph Tanzi | Co-Founder | Leadership |
Elam Jayamani | Co-Founder & Chief Technology Officer | Leadership |
Gary Ruvkun | Co-Founder | Leadership |
Murali Doraiswamy | Advisor | Board & advisors |
Mukesh Chatter | Board Member | Board & advisors |
Todd Herrington | Advisor | Board & advisors |
Zachary Gund | Board Member | Board & advisors |
Nitin Nohria | Advisor | Board & advisors |
Peter H. Diamandis | Advisor | Board & advisors |
Li Tso | Advisor | Board & advisors |
John Ripple | Advisor | Board & advisors |
Peter Dolan | Advisor | Board & advisors |
Complete people profiles for MarvelBiome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MarvelBiome
3 dated milestones of MarvelBiome across 6 years, from founding to its latest funding, stage changes and deals.
- Founded MarvelBiome is founded.
- Funding First funding round of $3.1M.
- Funding Latest funding round, Series C, of $39.6M.
Competitors of MarvelBiome
MarvelBiome has 3 listed competitors in our database, 3 of them funded. They include BridgeBio, Spark Therapeutics and Alnylam.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. | |
| alnylam.com | 2002 | Cambridge, United States | $17M | 2,100 | RNA interference-based therapeutics are developed for multiple disorders. |
Detailed competitors of MarvelBiome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MarvelBiome
Websites that share an audience with MarvelBiome (marvelbiome.com).
Websites whose visitors overlap most with MarvelBiome. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cardurion.com | 94% | 3.8K | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as MarvelBiome (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MarvelBiome
MarvelBiome was founded in 2019 and raised its 1st funding round 1 year after it was founded.
MarvelBiome is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
MarvelBiome is a funded company, having raised a total of $52.66M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.1M, raised on Nov 2020.
MarvelBiome has 10 employees.
MarvelBiome was founded in 2019 and is headquartered in Woburn, United States. Focus is placed on biotechnology operations involving the microbiome for therapeutic development. Microbial populations are isolated, identified, and characterized through assay methods and bacterial genetic techniques. Services support the creation of treatments based on microbial insights, serving the health sector with research-driven approaches.
MarvelBiome's top competitors include Spark Therapeutics, BridgeBio and Alnylam.
MarvelBiome offers Microbiome Research Service and Wellness Innovation Platform.
MarvelBiome operates through Marvelbiome Inc.